Autolus Therapeutics (AUTL) U.S. CCO reports option and RSU holdings

robot
Abstract generation in progress

Autolus Therapeutics plc’s U.S. CCO & Country General Manager, Cintia Piccina, has filed a Form 3 disclosing her existing equity awards. These holdings include share options for 500,000 American Depositary Shares at an exercise price of $1.49 and 148,000 ADS at $1.62, expiring in 2035 and 2036 respectively. She also holds restricted share units (RSUs) for 80,000 ADS and 33,000 ADS, which will vest in equal annual installments starting in September 2026 and March 2027.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin